LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

BCI® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other ...

OpenAI recently confirmed that it has invested in its co-founder Sam Altman's Merge Labs, a brain computer interface startup.

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

OpenAI has invested in Merge Labs, a brain-computer interface (BCI) startup co-founded by OpenAI CEO Sam Altman. The startup ...

Lewes, Delaware, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Global Brain Computer Interface (BCI) Market Size is projected to grow at a CAGR of 14.61 % from 2026 to 2032, according to a new report ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

What are brain-computer interfaces? Brain-computer interfaces (BCIs) are devices that allow for the action or control of an external device from brain signals. These technologies have a broad range of ...

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...

The MarketWatch News Department was not involved in the creation of this content. Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce ...

OpenAI is participating in a $250 million seed round into Merge Labs, Sam Altman's brain computer interface startup. The ...